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Abstract
Introduction: Serum vitamin D concentration is a major contributing factor for increasing the risk of fall and
fall-related injuries in older adults. However, when prescribed and supplemented for these populations, the
outcomes are controversial, and in several cases no improvement has been reported in reducing the risk of
recurrent falls. This study aimed to examine the association between serum vitamin D concentration and recurrent
falls in Iranian older adults.
Methods: This cohort study was conducted in the emergency departments of two university hospitals. A cohort
of 82 elderly participants aged over 60 and suffered from an unintentional episode of falling was evaluated six
months after their first ED visit. A structured, self-administered checklist was developed to obtain the
participants’ demographic and clinical information. Participants also were asked about any recurrent fall
experience during follow-up.
Results: The mean (SD) age of the study population was 75 (8). Over half of the participants were male (57.3%).
The mean (median) serum 25-hydroxyvitamin D (25 (OH)D) concentration was 38 (34) ng/ml. Mean serum
25(OH)D levels varied slightly between gender groups (p=0.450). An inverse but insignificant association was
found between the age of participants and their serum 25(OH)D levels (r=-0.03, p=0.7). A small but insignificant
association also was found between the mean serum 25(OH)D level and the number of recurrent falls in elderly
patients irrespective of their age, gender, or physical activity groups (OR=1.008, p=0.992).
Conclusion: In contrast to previous studies, no significant association of serum 25(OH)D concentration was
found with recurrent falls in Iranian older adults.
Keywords: 25-hydroxyvitamin D,falls, Vitamin D insufficiency, Iran, Elderly
1. Introduction
Falls are the leading cause of injury and deaths among older adults worldwide with an estimated 424,000 cases
reported each year (1). Over 30% of those aged over 65 or older and 40-50% of those over 80 currently are treated
for fall-related injuries (2). Recurrent falls among older adults have a significant financial, social, psychological, and
health-related burden on society, particularly on the health care system. Since falls and fall-related injuries result in
the loss of over 17 million disability-adjusted life years (DALYs), they are considered to be a major public health
http://www.ephysician.ir
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challenge across the world that calls for global action. In this context, the rapidly increasing number of older adults
and the associated risk of fall-related injuries underlines ongoing concerns about the quality of life, costs of care,
and demands for support services and preventive programs for vulnerable populations. Serum Vitamin D
insufficiency has been implemented as a major risk factor for osteoporosis, muscle weakness (3), falls(2, 4),
fractures(5, 6) and even mortality (7-9).The association between vitamin D insufficiency and the risk of fracture and
injuries has been estimated in several studies (5, 6, 10, 11). Most of the studies have investigated the effect of serum
25-hydroxyvitamin D (25(OH)D) concentration, which is the best indicator of vitamin D status, on bone mineral
density (BMD) changes (6, 12, 13). Therefore, it has been suggested that vitamin D is a major determinant of bone
health. It also has been indicated that low 25(OH)D levelshave been associated with low BMD in older white adults
(12, 14). In this regard, further investigations indicated a positive association between serum 25(OH)D and BMD of
the hip(5, 6, 11)and spine in men. Some other studies have suggested that vitamin D has a protective effect on
fractures by improving muscle functions and reduced risk of falling (2-4, 8). In these studies, low 25(OH)D was
found to be associated with poor grip strength, an indicator of muscle strength, balance, and increased risk of
mortality in elderly patients. Despite its well-documented protective effects, serum 25(OH)D concentration is likely
to be one of the most globally-considered contributing factors to BMD changes, muscle strength, fractures, and falls.
Serum 25(OH)D supplementation has been prescribed repeatedly as a preventive drug for older people, yet there are
surprising small number of well-documented randomized, controlled trials measuring its efficacy and potential to
reduce the risk of fractures and falls (15). Prescription of vitamin D supplementation for older people is based on
clinical experience rather than well documented, randomized trials that involve an extensive population with
different outcomes (15). While a great body of the literature suggests vitamin D supplementation as the major
contributing factors for reducing the risk of falls and fractures in elderly people, it is unclear whether its efficacy and
potential performance leads to better results. Therefore, further efforts are needed to investigate the effect of serum
25(OH)D concentration on the risk of falls in older populations. Recent data have failed to find any protective effect
of 25(OH)D on the risk or rates of falling in older people, yet the association between 25(OH)D concentration level
and the risk of falling in older adults has been a topic of heavy debate among healthcare professionals, and,
therefore, more investigations are needed to provide evidence of how 25(OH)D status is associated with the risk of
recurrent falls. In an attempt to address these challenges, the present study aimed to conduct a preliminary
investigation of the association between serum 25(OH)D levels and the risk of recurrent falls in the elderly Iranian
population.
2. Material and Methods
2.1. Study Setting and Participants
This cohort study was conducted in the emergency departments (EDs) of Rasoul Akram and Sina Hospitals during
March 2012- January 2013. A cohort of elderly participants over 60 who suffered from an unintentional episode of
falling was evaluated six months after of their first ED visit. Of all 120 patients invited to participate in the study, 82
ultimately remained to the end of the study. Exclusion criteria were the use of vitamin D supplements, anti-seizure
medications, or glucocorticoids.
2.2. Data collection and Follow-up
A structured, self-administered checklist was developed to obtain the participants’ demographic and clinical
information. The questionnaire included demographic information (age, gender, level of education, marital status),
past medical history, and serum 25(OH)D concentration of included participants at the time of hospitalization. This
checklist was completed during admission and in a six-month of follow up through telephone calls to the patients,
their family, or caregivers who were aware of the patients’ conditions. We also asked about any recurrent fall
experience during the six-month follow-up. Those who reported recurrent falls were asked about the frequency of
their falls.
2.3. 25(OH)D Analysis and Statistical analysis
A valid serum 25(OH)D sample was obtained from all of the patients who participated in the study. Non-fasting
blood samples were collected from participants during their first visit to the clinic. The serum concentration of
25(OH)D was measured by separating the serum from 5 cm3of clotted blood taken from the participants. All
samples were stored at -20oC and then transferred to the Reference Laboratory. The serum 25(OH)D concentration
was measured using the Enzyme-Linked Immunosorbent Assay (ELISA) method. Data analysis was performed
using Stata version 12 (Stata Corp., College Station, TX). Descriptive statistics (mean, median, SD and range) were
used to present the overall characteristics of the participants. Spearman’s regression coefficient was used to measure
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the associations between the quantitative variables. In order to compare the mean serum 25(OH)D concentration
between different categorical variables, the Mann-Whitney U and Kruskal-Wallis tests were used.
2.4. Ethics Approval and Informed Consent
All participants gave written informed consent. Ethical approval was granted by the Iran University of Medical
Sciences’ Research Ethics Committee.
3. Results
3.1. Characteristics of Participants
The mean (SD) age of the study population was 75 (8). Over half of the participants were male (57.3%), and about
80% lived in private homes. Table 1 presents the participants’ characteristics according to the three levels of serum
25(OH)D studied.
Table 1. Descriptive Characteristics of Participants, Aged 60 and Older Living in the Community According to
Serum 25(OH)D Level








Gender Male 47 (57.3) 39.1 (36) 16 (45.7) 30(66.7) 1 (50)
Female 35 (42.7) 36.8 (28) 19 (54.3) 15 (33.3) 1 (50)
Marital state Married 52 (63.4) 38.5 (36) 21 (60) 30 (66.7) 1 (50)
Widow 26 (31.7) 37.3(39) 13 (37.1) 12 (26.7) 1(50)
Single 4 (4.9) 37.7 (40.5) 1 (2.9) 3 (6.7) 0 (0)
Residence Private home 65 (79.3) 37.06 (34) 28 (80) 36 (80) 1 (50)
Children’s home 17 (20.7) 42.2 (34) 7 (20) 9 (20) 1 (50)
Age (year) 60-70 29 (35.4) 36.3 (33) 14 (40) 14 (31.1) 1 (50)
71-80 34 (41.5) 43.4 (37) 14 (40) 19 (42.2) 1 (50)
81-90 16(19.5) 34.2 (34.5) 4 (11.4) 12 (26.7) 0 (0)
>90 3(3.7) 15.3 (10) 3 (8.6) 0 (0) 0 (0)
Past medical
history
DM 16 (19.5) 41.3(30) 8 (22.9) 7 (15.6) 1 (50)
HTN 23 (28.1) 36.5 (36) 8 (22.9) 14 (31.1) 1 (50)
HLP 13 (15.8) 34 (36) 5 (14.3) 8 (17.8) 0
CAD 18 (21.9) 39.1 (29) 10 (28.6) 8 (17.8) 0
CVA 12 (14.6) 39.8 (36.5) 4 (11.4) 8 (17.8) 0
BMI
(kg/M2)
<20 8 (9.8) 42.7 (29) 4 (11.4) 3 (6.7) 1 (50)
20-24.9 38(46.3) 37.7 (36) 14 (40) 23 (51.1) 1 (50)
25-29.9 31(37.8) 38(33) 15 (42.9) 16 (35.6) 0 (0)
>30 5 (6.1) 33.6 (31) 2 (5.7) 3 (6.7) 0 (0)
Physical
activity
<80 75(91.5) 36.2 (32) 39 (86.7) 1 (50)
>80 7 (8.5) 58.8 (42) 6 (13.3) 1 (50)
Muscle
weakness
Yes 6 (7.3) 34.1 (32) 2 (5.7) 4 (8.9) 0 (0)
No 76 (92.7) 38.4 (34.5) 33 (94.3) 41 (91.1) 2 (100)
Dynamic
balance
Good 39 (47.6) 36.7 (36) 16 (45.7) 23 (51.1) 0 (0)
Poor, not
completed
43 (52.4) 39.3 (33) 19 (54.3) 22 (48.9) 2 (100)
3.2. Distribution of Serum 25(OH)D Concentration
The mean (median) serum 25(OH)D concentration was  38 (34) ng/ml. Mean serum 25(OH)D levels varied little
according to gender groups, men had higher levels of 25(OH)D rather than women (39.1 vs. 36.8, respectively,
p=0.450). In addition, mean serum 25(OH)D levels differed between the age groups, ranging from 15.3 ng/ml in
those aged over 90 to 43.4 ng/ml in those aged 71-80. According to this finding, an inverse, but insignificant,
association was found between the age of participants and their serum 25(OH)D levels (r=-0.03, p=0.7). Table 1
indicates that the mean serum 25(OH)D levels decreased according to BMI categories (from 42.7 to 33.6 ng/ml,
P=0.986). Mean serum 25(OH)D level was significantly higher in the group with physical activity of more than 80
min per week (P=0 .03). However, the mean serum 25(OH)D level was found to have no significant association with
muscle weakness(p=0.979) or dynamic balance scores(p=0.90).
http://www.ephysician.ir
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3.3. The Effect of Serum 25(OH)D Concentration on Falls
Figure 1 indicates the distribution of serum 25(OH)D according to recurrent falls and gender categories. According
to this figure, the median serum 25(OH)D concentration was higher in men than in women. Besides, the median
serum 25(OH)D concentration was decreased insignificantly in line with the increasing number of recurrent falls.
However, in women, the median of the serum 25(OH)D concentration followed a different pattern, in which women
who experienced recurrent falls had higher scores of serum 25(OH) than others (p=0.643).According to these
findings, a small but insignificant association was found between the mean serum 25(OH)D level and the number of
recurrent falls  in elderly patients irrespective of their age, gender, or physical activity groups (OR=1.008, p=0.992).
Figure 1. Distribution of Serum 25(OH)D according to recurrent falls and gender categories in participants aged 60
and older in the community
4. Discussion
In this prospective cohort study of elderly people that were treated in emergency rooms for injuries from falls, no
significant association was observed between their serum 25(OH)D concentration and recurrent falls. In addition,
mean serum 25(OH)D concentration was not associated with muscle weakness and balance in older adults. In this
study, no significant association of 25(OH)D was found with incidence of one or more recurrent falls. In contrast to
previous reports, our findings did not support the argument that vitamin D concentration reduces the risk of
recurrent falls in elderly people. Similar to our findings, in a survey by Faulkner et al., the relationship between
serum concentration of vitamin D metabolites and falls in older women in the United States was examined, and it
was reported that the risk of falling only decreased with high serum 1,25(OH)2D3 concentration, whereas higher
25(OH)D level was not associated with lower risk (16). Serum 1,25(OH)2D3 concentration was not assessed in
participants in our study because of laboratory limitations, but our findings confirmed the second result of this study
in that is showed that there was no association between 25(OH) D levels and falls. In a meta-analysis of randomized
controlled trials, the efficacy of the administration of vitamin D and calcium supplements in elderly people to reduce
the frequency of falls was examined, but the results found no efficacy (10). The findings of previous studies have
suggested that low vitamin D status is associated with increased risk of falling and fractures. Therefore, vitamin D
supplementation has been implemented as a strategy in increasing BMD and reducing the risk of fractures or falls in
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older people. Vitamin D concentration has been suggested repeatedly to be the contributing factor for BMD
changes, falls, fractures, and physical performance in older people, but emerging evidence highlights ongoing
debates on the protective effect of vitamin D concentration on falls and fractures. While prescribing vitamin D for
preventing unfavorable outcomes of bone resorption and turnover is based on clinical practice and cohort studies,
there is now evidence that failed to identify any protective effect of vitamin D supplementation on the risk or rate of
falling in older people (both in healthcare facilities or hospitals and in the community) (15, 17, 18).Our findings also
indicated no significant association of 25(OH)D concentration and muscle weakness in older adults. This result was
consistent with the findings of a systematic review and meta-analysis that examined the effect of vitamin D
concentration on muscle strength in adults (19). According to this evidence, vitamin D supplementation showed no
significant effect on grip strength, knee flexion strength, or knee extension strength in adults with baseline 25(OH)D
>25 nmol/L. These results provided further evidence that the function, metabolism, and absorption of vitamin D
may differ among individuals and even across diverse populations (15). However, limited early investigations have
suggested an increase in proximal muscle strength in adults with vitamin D deficiency (3). In this context, universal
recommendations on the use of vitamin D supplementation to improve muscle strength and physical performance of
older adults’ require further evidence. Our study was limited in several aspects. First, the design of our study did not
allow us to investigate the causality effect of vitamin D and recurrent falls. Also, we did not consider important
covariates, including body mass index, education, smoking, use of alcohol, and health status when we analyzed the
potential associations between serum vitamin D concentration and recurrent falls in older people. In addition, a
single baseline measurement of serum vitamin D, was used to categorize the participants, and this could have led to
misclassification of the participants, because single baseline measurements may not have reflected their long-term
biochemical status. We excluded those subjects who took vitamin D supplements during the six-month follow-up.
The efficacy of vitamin D supplements in reducing recurrent falls was not investigated in our study. Despite these
limitations, this study has several unique strengths. First, this is the first population-based study to examine the
incidence of recurrent fractures with serum vitamin D concentration in the Iranian population. Therefore, these
findings provide further evidence of the effect of vitamin D on recurrent falls in people with diverse ethnic
backgrounds. Second, this study used direct serum measures of vitamin D instead of other indirect measures,
including questionnaire-based scales or food frequency intakes of vitamin D-rich foods. In summary, our study
findings failed to support the argument that vitamin D concentration is associated with the reduced risk of falling in
older adults. No significant association of vitamin D was found with incidence of recurrent falls, muscle activity,
and balance.
5. Conclusions
The association between vitamin D insufficiency and the risk of fracture and injuries has been investigated
repeatedly, but the results remain controversial across different populations. Therefore, this study aimed to
investigate the protective role of vitamin D concentration against falls in the elderly Iranian population. By using
serum vitamin D concentration as a direct measure of vitamin D, this study failed to support the argument that
vitamin D concentration is associated with the reduced risk of falling in older adults. According to our findings, no
significant association was observed between serum vitamin D concentration and recurrent falls, muscle activity,
and balance. Our findings provided further evidence that the function, metabolism, and absorption of vitamin D may
differ among individuals and even across diverse populations. Yet, the results are still incomplete, and further trials
are needed to reach conclusive decisions.
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